To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CBX4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
85 supporting clones for gene CBX4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DN995463 breast cancer, Mammary gland (cancer tissue) .a 1 to 502 1 to 502       502/502
(100 %)
3 diff
(99.5 %id)
BM451430 eye, retinoblastoma .a 3 to 749 18 to 779       762/1029
(74 %)
29 diff
(97.2 %id)
EU439707   .a 3 to 2528 18 to 2548   tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 2531/2548
(99 %)
11 diff
(99.6 %id)
DN999973   .a 6 to 651 7 to 653   tiling clone,   647/653
(99 %)
10 diff
(98.5 %id)
BM475166 duodenal adenocarcinoma, cell line, small intestine .a 7 to 756 28 to 801       774/1040
(74 %)
36 diff
(96.6 %id)
BQ225831 embryonal carcinoma, cell line, testis .a 19 to 616 1 to 603       603/944
(63 %)
7 diff
(99.3 %id)
NM_003655.2   .a 19 to 2673 1 to 2655   RefSeq,   2655/2655
(100 %)
6 diff
(99.8 %id)
CR983722 T-Lymphocytes .a 46 to 588 1 to 543       543/543
(100 %)
3 diff
(99.5 %id)
CR980957 T-Lymphocytes .a 53 to 688 1 to 636       636/639
(99 %)
1 diff
(99.9 %id)
BQ049740 lymph, lymphoma, cell line .a 79 to 852 20 to 801       782/1118
(69 %)
19 diff
(98.4 %id)
DW409332 Liver .a 215 to 537 17 to 339       323/339
(95 %)
6 diff
(98.3 %id)
TI_159721692   .a 553 to 1361 885 to 91       795/1055
(75 %)
0 diff
(100 %id)
CF144881 CNCAP(3)T-225 cell line, Prostate .a 648 to 1119 7 to 478       472/478
(98 %)
10 diff
(98.0 %id)
TI_154176990   .a 648 to 1230 78 to 663       586/989
(59 %)
24 diff
(97.6 %id)
BM475109 duodenal adenocarcinoma, cell line, small intestine .a 673 to 1257 17 to 611       595/1066
(55 %)
23 diff
(97.9 %id)
CB852726 Human Lung Epithelial cells, lung .a 688 to 1361 702 to 31   AAA   672/684
(98 %)
0 diff
(100 %id)
BF339249 brain, glioblastoma with EGFR amplification .a 846 to 1342 26 to 535       510/985
(51 %)
35 diff
(96.5 %id)
CT005072 T-Lymphocytes .a 879 to 1581 1 to 704       704/704
(100 %)
1 diff
(99.9 %id)
R59323 whole brain .a 921 to 1248 324 to 1     Submitted on the opposite strand 324/329
(98 %)
4 diff
(98.8 %id)
AW859243 colon .a 962 to 1229 1 to 265       265/265
(100 %)
6 diff
(97.8 %id)
BQ639572 eye, retina .a 1027 to 1648 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
CR986431 T-Lymphocytes .a 1080 to 1939 8 to 867       860/870
(98 %)
2 diff
(99.8 %id)
BX280228 melanotic melanoma, skin .a 1109 to 1604 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BM452847 melanotic melanoma, skin .a 1109 to 1909 1 to 806       806/895
(90 %)
12 diff
(98.7 %id)
BM452215 melanotic melanoma, skin .a 1371 to 2277 21 to 935       915/1027
(89 %)
40 diff
(96.2 %id)
BI047861 stomach .a 1413 to 1589 1 to 175       175/175
(100 %)
4 diff
(97.8 %id)
CR983052 T-Lymphocytes .a 1502 to 2273 1 to 772       772/772
(100 %)
2 diff
(99.8 %id)
BX415851 thymus .a 1521 to 2452 1 to 927   AAA   927/1001
(92 %)
14 diff
(98.7 %id)
U94344   .a 1550 to 1861 1 to 312       312/312
(100 %)
5 diff
(98.4 %id)
BQ219412 epithelioid carcinoma, Pancreas .a 1553 to 2365 1 to 819       819/862
(95 %)
17 diff
(98.1 %id)
BU171393 melanotic melanoma, skin .a 1567 to 2391 1 to 837       837/929
(90 %)
44 diff
(95.3 %id)
BE621004 epithelioid carcinoma, Pancreas .a 1576 to 2292 1 to 721       721/804
(89 %)
15 diff
(98.2 %id)
BI836958 pooled pancreas and spleen .a 1643 to 2469 1 to 836       836/836
(100 %)
36 diff
(95.7 %id)
TI_57163817   .a 1643 to 2469 72 to 907       836/907
(92 %)
6 diff
(99.4 %id)
CR979963 T-Lymphocytes .a 1696 to 2391 1 to 696   tiling clone,   696/700
(99 %)
1 diff
(99.9 %id)
BM016493 breast, mammary adenocarcinoma, cell line .a 1739 to 1917 363 to 551       504/673
(74 %)
37 diff
(94.6 %id)
TI_59394110   .a 1739 to 1917 446 to 634       505/674
(74 %)
37 diff
(94.6 %id)
AV728671 hypothalamus .a 1753 to 2526 1 to 772       772/780
(98 %)
37 diff
(95.3 %id)
EC457885 Prostate .a 1767 to 1887 1 to 123       123/123
(100 %)
4 diff
(96.8 %id)
CR616461 thymus .a 1817 to 2528 1 to 712   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 712/712
(100 %)
0 diff
(100 %id)
BX436959 thymus .a 1817 to 2528 1 to 712   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 712/712
(100 %)
0 diff
(100 %id)
AI566550 anaplastic oligodendroglioma, brain .a 1909 to 2532 623 to 1       623/623
(100 %)
18 diff
(97.2 %id)
AI570531 anaplastic oligodendroglioma, brain .a 1938 to 2528 582 to 1       582/865
(67 %)
15 diff
(98.3 %id)
CD743207 Alveolar Macrophage, lung .a 1950 to 2546 598 to 1       598/598
(100 %)
1 diff
(99.9 %id)
AA485165 germinal center B cell .a 1954 to 2221 1 to 261       261/261
(100 %)
22 diff
(91.6 %id)
BX342833   .a 1967 to 2557 1 to 589       589/589
(100 %)
3 diff
(99.5 %id)
AA514477 colon .a 2030 to 2531 501 to 1       501/501
(100 %)
6 diff
(98.9 %id)
AI334227 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2055 to 2528 474 to 1       474/474
(100 %)
2 diff
(99.6 %id)
BG222508 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .a 2076 to 2534 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
AI351619   .a 2122 to 2531 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AI076023 brain, glioblastoma (pooled) .a 2140 to 2535 396 to 1       396/396
(100 %)
0 diff
(100 %id)
BP417408 small intestine .a 2141 to 2528 430 to 42   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 389/397
(97 %)
3 diff
(99.3 %id)
AI148768 placenta .a 2150 to 2530 381 to 1       381/381
(100 %)
0 diff
(100 %id)
AI796748 Kidney .a 2150 to 2667 524 to 7   tiling clone,   518/524
(98 %)
0 diff
(100 %id)
H10012 whole brain .a 2170 to 2539 372 to 1       372/372
(100 %)
6 diff
(98.4 %id)
R49482 whole brain .a 2191 to 2538 355 to 1       355/395
(89 %)
16 diff
(96.0 %id)
BF089132 head_neck .a 2202 to 2377 194 to 19       176/194
(90 %)
0 diff
(100 %id)
BF088541 head_neck .a 2203 to 2378 1 to 174       174/182
(95 %)
6 diff
(96.8 %id)
AW241686 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2204 to 2515 312 to 1       312/312
(100 %)
5 diff
(98.4 %id)
BU188400 melanotic melanoma, skin .a 2206 to 2665 1 to 456       456/465
(98 %)
3 diff
(99.4 %id)
DA571424 whole embryo, mainly head .a 2226 to 2528 2 to 304   fully sequenced, capped   303/303
(100 %)
1 diff
(99.7 %id)
BM989303 Fibrosarcoma .a 2245 to 2665 441 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 423/423
(100 %)
4 diff
(99.1 %id)
AA573349 colon .a 2256 to 2442 217 to 31       187/217
(86 %)
0 diff
(100 %id)
DB358277 whole embryo, mainly head .a 2272 to 2528 257 to 1   fully sequenced,   257/257
(100 %)
0 diff
(100 %id)
BX342008   .a 2274 to 2663 1 to 389       389/393
(98 %)
9 diff
(97.8 %id)
AI401035 Prostate .a 2276 to 2667 390 to 1       390/390
(100 %)
1 diff
(99.8 %id)
BF221869 Prostate .a 2276 to 2666 389 to 1       389/389
(100 %)
1 diff
(99.8 %id)
CB128696 Liver .a 2290 to 2666 1 to 370   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 370/370
(100 %)
3 diff
(99.2 %id)
BG149465 carcinoid, lung .a 2318 to 2665 360 to 11       350/370
(94 %)
0 diff
(100 %id)
D20381   .a 2352 to 2531 1 to 180     Submitted on the opposite strand 180/180
(100 %)
0 diff
(100 %id)
FN051660 breast carcinoma .a 2356 to 2472 1 to 119       119/119
(100 %)
2 diff
(98.4 %id)
AW591352 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2382 to 2667 283 to 2       282/283
(99 %)
0 diff
(100 %id)
BX436958 thymus .a 2383 to 2503 120 to 1   fully sequenced, Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 120/120
(100 %)
0 diff
(100 %id)
EH321891   .a 2579 to 2642 1 to 64       64/64
(100 %)
0 diff
(100 %id)
BC014967 Colon, adenocarcinoma .b 1 to 1556 1 to 1556 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1556/1556
(100 %)
0 diff
(100 %id)
TI_1948090957   .b 19 to 872 129 to 996   fully sequenced,   868/996
(87 %)
61 diff
(93.9 %id)
TI_1948091096   .b 19 to 586 122 to 691   fully sequenced,   570/691
(82 %)
7 diff
(99.0 %id)
AY390430   .b 20 to 892 1 to 873       873/873
(100 %)
0 diff
(100 %id)
CV028979 mixed .b 20 to 632 1 to 612       612/615
(99 %)
2 diff
(99.7 %id)
TI_1948091220   .b 29 to 492 129 to 597   fully sequenced,   469/597
(78 %)
8 diff
(98.7 %id)
TI_1948090834   .b 342 to 894 677 to 122       556/1333
(41 %)
13 diff
(99.1 %id)
TI_1948091221   .b 462 to 898 551 to 114   fully sequenced,   438/551
(79 %)
15 diff
(97.3 %id)
TI_1948091097   .b 556 to 898 458 to 115   fully sequenced,   344/458
(75 %)
5 diff
(99.0 %id)
TI_1948090958   .b 569 to 898 451 to 119   fully sequenced,   333/451
(73 %)
6 diff
(98.7 %id)
BQ308537 breast .c 1 to 500 19 to 519 L15F P16Q E17N Q18R G19E ... tiling clone,   501/594
(84 %)
12 diff
(98.0 %id)
CT003488 T-Lymphocytes .d 1 to 432 1 to 432 exact tiling clone,   432/432
(100 %)
0 diff
(100 %id)
CR982265 T-Lymphocytes .e 1 to 690 1 to 692 exact tiling clone,   692/722
(95 %)
3 diff
(99.6 %id)
BF980932 duodenal adenocarcinoma, cell line, small intestine .f 1 to 676 1 to 686 P12T L13R V14* tiling clone,   686/687
(99 %)
41 diff
(94.1 %id)
AF013956   Gene CBX4, variant not shown         Suspected internal deletion, this clone was ignored    
BG029608 breast, mammary adenocarcinoma, cell line Gene CBX4, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI